Procyanidin improves experimental colitis by regulating macrophage polarization

Area of Science:

• Immunology
• Gastroenterology
• Pharmacology

Background:

• Inflammatory bowel disease (IBD) presents a significant clinical challenge due to its unclear pathogenesis and limited effective treatments.
• Procyanidin, a natural antioxidant, has shown potential in ameliorating colitis, yet its precise mechanism of action remains largely unknown.

Purpose of the Study:

• To investigate the therapeutic effects of procyanidin on colitis models.
• To elucidate the role of procyanidin in regulating M1 macrophage polarization and associated signaling pathways.

Main Methods:

• In vivo studies utilized established colitis models (DSS-induced) to assess procyanidin's impact on macrophage polarization.
• In vitro experiments employed the RAW264.7 cell line and primary peritoneal macrophages to further validate findings.

Main Results:

• Procyanidin demonstrated efficacy in ameliorating dextran sulfate sodium (DSS)-induced colitis by inhibiting M1 macrophage polarization and reducing pro-inflammatory factors.
• The compound prevented lipopolysaccharide (LPS)-induced increases in inflammatory cytokines and macrophage activation via STAT3 and NF-κB pathways.

Conclusions:

• This research provides the first evidence that procyanidin alleviates experimental colitis by suppressing pro-inflammatory macrophage polarization.
• The findings offer novel insights into the pathogenesis of inflammatory diseases and suggest procyanidin as a potential therapeutic agent.